55 y/o female with a history of HTN, osteoporosis and menopausal symptoms. Her c

Question

55 y/o female with a history of HTN, osteoporosis and menopausal symptoms. Her current medications include calcium supplement, alendronate, Premarin, hydrochlorothiazide, and amlodipine. Should this pt. receive daily antiplatelet therapy for stroke prevention?

Yes. This pt. meets criteria for primary stroke prevention and has no contraindications against the use of antiplatelets.

Yes. This pt. meets the criteria for secondary stroke prevention and has no contraindications against the use of antiplatelets.

No. This pt. meets criteria for primary stroke prevention; however,antiplatelets are contraindicated in this pt.

No. This pt. meets criteria for secondary stroke prevention; however, antiplatelets are contraindicated in this pt.

No. This pt. does not meet criteria for either primary or secondary stroke prevention. She has no risk factors for developing stroke; therefore, antiplatelet therapy is not needed.

Explanation / Answer

C

Related Questions

Navigate

• Browse (All)
• Browse 5
• Subjects

Integrity-first tutoring: explanations and feedback only — we do not complete graded work. Learn more.